Albuminuria and renal insufficiency prevalence guides population screening

Garg, Amit X.; Kiberd, Bryce A.; Clark, William F.; Haynes, Richard; Clase, Catherine M.

doi:10.1046/j.1523-1755.2003.t01-1-00140.x

Cited by 5 publications

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9,10 The epidemiological surveys showed that prevalence of CKD was 13% in non-institutionalized adults of the United States. 11 The prevalence of proteinuria and hematuria in Japan was 4.7% in men, 3.5% in women and 2.8% in men, 11.0% in women, respectively. 12 The prevalence of CKD and albuminuria in China was 10.8% and 9.4%, respectively.…”

Section: Discussionmentioning

confidence: 93%

Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human

Duan

Pan

et al. 2014

Renal Failure

View full text Add to dashboard Cite

Objective: To evaluate the effects of Huai Qi Huang (HQH) granules on primary glomerulonephritis patients, and to discuss its possible mechanisms. Method: Sixteen patients diagnosed with primary glomerular disease between December 2011 and December 2012 were enrolled. Their blood and urine samples were collected at day 0 (the baseline levels), 30, and 90 of receiving HQH granules orally. Levels of creatinine and cystatin C (Cys-C) in serum and urine, and total protein and albumin in urine were measured by automatic biochemical analyzer. Neutrophil gelatinase-associated lipocalin (NGAL) in serum and urine was tested by ELISA; serum malondialdehyde (MDA) was measured by thiobarbituric acid method, the erythrocyte count in urine was calculated under light microscope. Results: Serum levels of creatinine, MDA, Cys-C and NGAL at day 30 and 90 were significantly lower than the baseline levels. Urinary levels of Cys-C, NGAL, total protein, albumin and erythrocyte counts were also decreased; level of estimated glomerular filtration (eGFR) was increased. Conclusion: HQH granules have certain effect on delaying the development of primary glomerular disease with mild proteinuria and hematuresis in patients. This study may supply a new treatment for primary glomerular diseases.

show abstract

Section: Discussionmentioning

confidence: 93%

Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human

Duan

Pan

et al. 2014

Renal Failure

View full text Add to dashboard Cite

show abstract

“…[9][10][11][12] In 2002-2003, higher prevalence rates of CKD of 16 and 14% were reported in USA in NHANES III ( 3 rd National Health and Nutrition Survey) and in Australia in AUS DIAB (the Australian diabetes, obesity and lifestyle study) respectively. 13,14 Over 80% of all patients who receive treatment for end stage kidney disease are reported from developed countries which are characterized by a large elderly population and access to healthcare facilities. 1 The annual incident rate of renal replacement therapy is much higher in affluent countries, ranging from 150 to 400 per million population (pmp) compared to 50 pmp in poor countries with limited access to healthcare.…”

Section: Prevalence and Incidencementioning

confidence: 99%

Current Trends in Chronic Kidney Disease

Berbari¹,

Daouk²,

Daouk³

2018

Nephrol Open J

View full text Add to dashboard Cite

Chronic kidney disease (CKD), a major contributor to health care burden, is defined by persistent indicators of renal structural and or functional abnormalities. Diabetes mellitus, hypertension, and obesity are important causes of chronic renal functional impairment. Increased consumption of carbonated beverages, high salt intake, smoking, and in developing countries, environmental toxic products, infections, pesticides, herbal medicines, use of contaminated water remain etiologic determinants of chronic nephropathy. CKD remains a high risk for cardiovascular disease and end-stage renal failure. Awareness by the public and healthcare providers of its determinants and its prognostic significance can prevent or reduce the development of CKD. In addition, adequate glycemic and blood pressure control preferably with blockers of the renin Angiotensin system are required therapeutic approaches. Acute kidney injury, a common complication of critically patients is associated with high mortality and, in survivals, of increased risk of CKD.

show abstract